Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Intensity Focused Ultrasound Ablation | 18 | 2025 | 48 | 9.430 |
Why?
|
| Microbubbles | 17 | 2025 | 40 | 4.500 |
Why?
|
| Thrombosis | 11 | 2025 | 315 | 3.910 |
Why?
|
| Ultrasonic Therapy | 9 | 2025 | 43 | 3.790 |
Why?
|
| Phantoms, Imaging | 17 | 2025 | 485 | 3.600 |
Why?
|
| Ultrasonography | 15 | 2025 | 709 | 3.480 |
Why?
|
| Tissue Plasminogen Activator | 8 | 2022 | 180 | 3.050 |
Why?
|
| Fibrinolytic Agents | 7 | 2022 | 242 | 2.850 |
Why?
|
| Thrombolytic Therapy | 7 | 2025 | 258 | 1.940 |
Why?
|
| Lithotripsy | 3 | 2023 | 42 | 1.930 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2025 | 1283 | 1.420 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 107 | 1.230 |
Why?
|
| Ultrasonics | 4 | 2013 | 37 | 1.210 |
Why?
|
| Liposomes | 6 | 2022 | 100 | 1.130 |
Why?
|
| Contrast Media | 8 | 2025 | 1006 | 1.070 |
Why?
|
| High-Energy Shock Waves | 3 | 2018 | 3 | 1.050 |
Why?
|
| Gases | 2 | 2018 | 31 | 0.910 |
Why?
|
| Venous Thrombosis | 3 | 2025 | 263 | 0.900 |
Why?
|
| Swine | 8 | 2025 | 588 | 0.870 |
Why?
|
| Fibrinolysis | 2 | 2022 | 35 | 0.870 |
Why?
|
| Patient Safety | 1 | 2024 | 229 | 0.720 |
Why?
|
| Skin Aging | 1 | 2021 | 31 | 0.690 |
Why?
|
| Cosmetic Techniques | 1 | 2021 | 28 | 0.690 |
Why?
|
| Erythrocytes | 2 | 2022 | 238 | 0.670 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 52 | 0.670 |
Why?
|
| Water | 2 | 2012 | 310 | 0.650 |
Why?
|
| Elastic Modulus | 1 | 2019 | 35 | 0.600 |
Why?
|
| Gels | 1 | 2019 | 52 | 0.600 |
Why?
|
| Elasticity | 2 | 2022 | 98 | 0.590 |
Why?
|
| Robotics | 1 | 2021 | 270 | 0.540 |
Why?
|
| Mechanical Thrombolysis | 2 | 2014 | 18 | 0.540 |
Why?
|
| In Vitro Techniques | 4 | 2022 | 945 | 0.530 |
Why?
|
| Ultrasonic Surgical Procedures | 1 | 2016 | 6 | 0.480 |
Why?
|
| Fluorocarbons | 5 | 2016 | 64 | 0.460 |
Why?
|
| Blood Cells | 1 | 2014 | 32 | 0.430 |
Why?
|
| Biomarkers | 1 | 2021 | 1977 | 0.430 |
Why?
|
| Models, Biological | 3 | 2017 | 1792 | 0.430 |
Why?
|
| Blood Coagulation | 1 | 2014 | 90 | 0.420 |
Why?
|
| Liver | 1 | 2019 | 1222 | 0.420 |
Why?
|
| Humans | 25 | 2024 | 96382 | 0.420 |
Why?
|
| Animals | 13 | 2025 | 28471 | 0.410 |
Why?
|
| Algorithms | 3 | 2025 | 1974 | 0.400 |
Why?
|
| Recombinant Proteins | 4 | 2022 | 988 | 0.400 |
Why?
|
| Mechanical Phenomena | 1 | 2012 | 18 | 0.380 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2025 | 200 | 0.370 |
Why?
|
| Acoustics | 4 | 2021 | 46 | 0.370 |
Why?
|
| ROC Curve | 3 | 2019 | 789 | 0.360 |
Why?
|
| Transducers | 2 | 2021 | 37 | 0.340 |
Why?
|
| Light | 1 | 2012 | 290 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 3562 | 0.320 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 785 | 0.290 |
Why?
|
| Models, Theoretical | 3 | 2018 | 500 | 0.270 |
Why?
|
| Motion | 2 | 2018 | 95 | 0.230 |
Why?
|
| Pressure | 4 | 2014 | 167 | 0.230 |
Why?
|
| Femoral Vein | 1 | 2025 | 42 | 0.220 |
Why?
|
| Prostate | 2 | 2018 | 421 | 0.210 |
Why?
|
| Vibration | 3 | 2014 | 30 | 0.210 |
Why?
|
| Equipment Design | 2 | 2016 | 423 | 0.190 |
Why?
|
| Kidney | 2 | 2025 | 1114 | 0.180 |
Why?
|
| Esthetics | 1 | 2021 | 52 | 0.170 |
Why?
|
| Linear Models | 2 | 2012 | 422 | 0.170 |
Why?
|
| Blood Platelets | 1 | 2022 | 151 | 0.170 |
Why?
|
| Computer Simulation | 2 | 2018 | 1148 | 0.170 |
Why?
|
| Hemoglobins | 1 | 2022 | 194 | 0.170 |
Why?
|
| Catheters | 1 | 2022 | 109 | 0.170 |
Why?
|
| Time Factors | 3 | 2025 | 5524 | 0.150 |
Why?
|
| Mice | 3 | 2023 | 12495 | 0.150 |
Why?
|
| Neuroblastoma | 1 | 2023 | 404 | 0.140 |
Why?
|
| Silicon Dioxide | 1 | 2018 | 40 | 0.140 |
Why?
|
| Diffusion | 1 | 2018 | 94 | 0.140 |
Why?
|
| Scattering, Radiation | 1 | 2018 | 122 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 460 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 121 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1738 | 0.120 |
Why?
|
| Cell Survival | 1 | 2018 | 1012 | 0.120 |
Why?
|
| Lipids | 2 | 2014 | 289 | 0.110 |
Why?
|
| Radiation Dosage | 1 | 2014 | 231 | 0.100 |
Why?
|
| Phospholipids | 1 | 2013 | 108 | 0.100 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 76 | 0.100 |
Why?
|
| Parietal Bone | 1 | 2012 | 16 | 0.090 |
Why?
|
| Surface Tension | 1 | 2012 | 9 | 0.090 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2012 | 33 | 0.090 |
Why?
|
| Male | 4 | 2019 | 46116 | 0.090 |
Why?
|
| Temporal Bone | 1 | 2012 | 63 | 0.090 |
Why?
|
| Surface Properties | 1 | 2012 | 128 | 0.090 |
Why?
|
| Likelihood Functions | 1 | 2012 | 257 | 0.090 |
Why?
|
| Aged | 2 | 2019 | 21309 | 0.090 |
Why?
|
| Temperature | 1 | 2012 | 436 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1118 | 0.080 |
Why?
|
| Middle Aged | 2 | 2019 | 28794 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2025 | 36 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2025 | 138 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 2640 | 0.050 |
Why?
|
| Heterografts | 1 | 2023 | 120 | 0.050 |
Why?
|
| Thrombin | 1 | 2022 | 60 | 0.050 |
Why?
|
| Cattle | 1 | 2022 | 397 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 397 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2023 | 829 | 0.040 |
Why?
|
| Adult | 1 | 2019 | 28968 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 706 | 0.040 |
Why?
|
| Female | 2 | 2023 | 50528 | 0.040 |
Why?
|
| Emulsions | 1 | 2018 | 19 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 636 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2528 | 0.030 |
Why?
|
| Hypoxia | 1 | 2023 | 691 | 0.030 |
Why?
|
| Apoptosis | 1 | 2023 | 1731 | 0.030 |
Why?
|
| Sound | 1 | 2014 | 24 | 0.030 |
Why?
|
| Sonication | 1 | 2013 | 5 | 0.030 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2013 | 32 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1934 | 0.020 |
Why?
|
| Software | 1 | 2013 | 684 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2764 | 0.020 |
Why?
|